Proteomic markers with prognostic impact on outcome of chronic lymphocytic leukemia patients under chemo-immunotherapy: results from the HOVON 109 study

Fatemeh Saberi Hosnijeh; Lina van der Straten; AP Kater; MH van Oers; WFM Posthuma; ME Chamuleau; M Bellido; Jeanette Doorduijn; M Gelder; M Hoogendoorn; F Boer; GD te Raa; JM Kerst; EWA Marijt; RA Raymakers; HR Koene; MR Schaafsma; JA Dobber; SH Tonino; SS Kersting; Ton Langerak; MD Levin

doi:10.1016/j.exphem.2020.08.002

Proteomic markers with prognostic impact on outcome of chronic lymphocytic leukemia patients under chemo-immunotherapy: results from the HOVON 109 study

Fatemeh Saberi Hosnijeh, Lina van der Straten, AP Kater, MH van Oers, WFM Posthuma, ME Chamuleau, M Bellido, Jeanette Doorduijn, M Gelder, M Hoogendoorn, F Boer, GD te Raa, JM Kerst, EWA Marijt, RA Raymakers, HR Koene, MR Schaafsma, JA Dobber, SH Tonino, SS KerstingTon Langerak, MD Levin

Research output: Contribution to journal › Article › Academic › peer-review

2 Citations (Scopus)

6 Downloads (Pure)

Original language	English
Pages (from-to)	55-60.e6
Journal	Experimental Hematology
Volume	89
DOIs	https://doi.org/10.1016/j.exphem.2020.08.002
Publication status	Published - 2020

Access to Document

10.1016/j.exphem.2020.08.002

Repub_129979_O-A.pdfFinal published version, 1.78 MB

Cite this

Saberi Hosnijeh, F., van der Straten, L., Kater, AP., van Oers, MH., Posthuma, WFM., Chamuleau, ME., Bellido, M., Doorduijn, J., Gelder, M., Hoogendoorn, M., Boer, F., te Raa, GD., Kerst, JM., Marijt, EWA., Raymakers, RA., Koene, HR., Schaafsma, MR., Dobber, JA., Tonino, SH., ... Levin, MD. (2020). Proteomic markers with prognostic impact on outcome of chronic lymphocytic leukemia patients under chemo-immunotherapy: results from the HOVON 109 study. Experimental Hematology, 89, 55-60.e6. https://doi.org/10.1016/j.exphem.2020.08.002

@article{8c26ac025d1749208a10c5ac91427cb9,

title = "Proteomic markers with prognostic impact on outcome of chronic lymphocytic leukemia patients under chemo-immunotherapy: results from the HOVON 109 study",

author = "{Saberi Hosnijeh}, Fatemeh and {van der Straten}, Lina and AP Kater and {van Oers}, MH and WFM Posthuma and ME Chamuleau and M Bellido and Jeanette Doorduijn and M Gelder and M Hoogendoorn and F Boer and {te Raa}, GD and JM Kerst and EWA Marijt and RA Raymakers and HR Koene and MR Schaafsma and JA Dobber and SH Tonino and SS Kersting and Ton Langerak and MD Levin",

year = "2020",

doi = "10.1016/j.exphem.2020.08.002",

language = "English",

volume = "89",

pages = "55--60.e6",

journal = "Experimental Hematology",

issn = "0301-472X",

publisher = "Elsevier Inc.",

}

Saberi Hosnijeh, F, van der Straten, L, Kater, AP, van Oers, MH, Posthuma, WFM, Chamuleau, ME, Bellido, M, Doorduijn, J, Gelder, M, Hoogendoorn, M, Boer, F, te Raa, GD, Kerst, JM, Marijt, EWA, Raymakers, RA, Koene, HR, Schaafsma, MR, Dobber, JA, Tonino, SH, Kersting, SS, Langerak, T & Levin, MD 2020, 'Proteomic markers with prognostic impact on outcome of chronic lymphocytic leukemia patients under chemo-immunotherapy: results from the HOVON 109 study', Experimental Hematology, vol. 89, pp. 55-60.e6. https://doi.org/10.1016/j.exphem.2020.08.002

TY - JOUR

T1 - Proteomic markers with prognostic impact on outcome of chronic lymphocytic leukemia patients under chemo-immunotherapy: results from the HOVON 109 study

AU - Saberi Hosnijeh, Fatemeh

AU - van der Straten, Lina

AU - Kater, AP

AU - van Oers, MH

AU - Posthuma, WFM

AU - Chamuleau, ME

AU - Bellido, M

AU - Doorduijn, Jeanette

AU - Gelder, M

AU - Hoogendoorn, M

AU - Boer, F

AU - te Raa, GD

AU - Kerst, JM

AU - Marijt, EWA

AU - Raymakers, RA

AU - Koene, HR

AU - Schaafsma, MR

AU - Dobber, JA

AU - Tonino, SH

AU - Kersting, SS

AU - Langerak, Ton

AU - Levin, MD

PY - 2020

Y1 - 2020

U2 - 10.1016/j.exphem.2020.08.002

DO - 10.1016/j.exphem.2020.08.002

M3 - Article

SN - 0301-472X

VL - 89

SP - 55-60.e6

JO - Experimental Hematology

JF - Experimental Hematology

ER -